Executive summary and recommendations from WHO/UNAIDS and AAVP consultation on: 'The inclusion of adolescents in HIV vaccine trials', 16-18 March 2006 in Gaborone, Botswana

AIDS

Volumn 21, Issue 14, 2007, Pages

  Sheets, B ^b   Folb, P ^b   Wassenar, D ^b   Barsdorf, N ^b   MacKlin, R ^b   Wasserheit, J ^b   Kieny, M P ^b   Hankins, C ^b   Osmanov, S ^a   Toure C ^b   Hutubessy, R ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENCE; BOTSWANA; CLINICAL RESEARCH; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; EPIDEMIC; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MEDICAL ETHICS; MEDICAL PRACTICE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; VACCINATION;

ADOLESCENT; AFRICA SOUTH OF THE SAHARA; AIDS VACCINES; ATTITUDE TO HEALTH; CHILD; CLINICAL TRIALS; CONSUMER PARTICIPATION; HEALTH PLANNING GUIDELINES; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; RESEARCH DESIGN; UNITED NATIONS; WORLD HEALTH ORGANIZATION;

EID: 34548218872     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282f086f5     Document Type: Review

References (14)

1. UNAIDS/WHO. AIDS epidemic update: December 2006. Available at: http://www.unaids.org/en/ Accessed: July 2007.
2. UNAIDS. 2006 Report on the Global AIDS epidemic. Available at: http://www.unaids.org/en/ Accessed: July 2007.
3. WHO/UNAIDS expert group. Gender, age, and ethnicity in HIV vaccine-related research and clinical trials: report from a WHO/UNAIDS consultation, 26-28 August 2004, Lausanne Switzerland. AIDS 2005; 19: w7-w28.
4. Duerr A, Wasserheit JN, Corey L. HIV vaccines: new fronteers in vaccine development. Clin Infect Dis 2006; 43:501-511.
5. McMichael AJ. HIV vaccines. Annu Rev Immunol 2006; 24: 739-769.
6. Rodriguez-Chavez IR, Allen M, Hill EL, Sheets RL, Pensiero M, Bradac JA, D'Souza MP. Current advances and challenges in HIV-1 vaccines. Curr HIV/AIDS Rep 2006; 3:39-47.
7. Spearman P. Current progress in the development of HIV vaccines. Curr Pharm Des 2006; 12:114-1167.
8. Girard M, Osmanov S, Kieny M-P. A review of vaccine research and development: the human immunodeficiency virus (HIV). Vaccines 2006; 24:4062-4081.
9. Society for Adolescent Medicine. Guidelines for adolescent health research. J Adol Health 2003; 33: 396-409.
10. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects, 2004. Available at: http://www.wma.net/e/policy/b3.htm. Accessed: July 2007
11. UNAIDS. Guidance document. Ethical considerations in HIV preventive vaccine research, 2000. Available at: http://data. unaids.org/Publications/ IRC-pub01/JC072-EthicalCons_en.pdf. Accessed: July 2007.
12. Jaspan HB, Gray GE, Robinson AK, Coovadia HM, Bekker LG. Scientific justification for the participation of children and adolescents in HIV-1 vaccine trials in South Africa. S Afr Med J 2005; 95:685-687.
13. Jaspan HB, Lawn SD, Safrit JT, Bekker LG. The maturing immune system: implications for development and testing HIV-1 vaccines for children and adolescents. AIDS 2006; 20:483-494.
14. Milford C, Wassenaar DR, Slack CM. Resources and needs of research ethics committees in Africa: preparations for HIV vaccine trials. IRB 2006; 28:1-9.